Open Access

Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma

  • Authors:
    • Jian Chen
    • Fan Zhang
    • Dong Wang
    • Zhongjun Yang
    • Shaohua Liu
    • Zuoqing Dong
  • View Affiliations

  • Published online on: April 2, 2020     https://doi.org/10.3892/ol.2020.11506
  • Pages: 3917-3922
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

DNA-binding protein inhibitor ID-1 (ID-1) plays a vital role in the development of cancer. In the present study, ID‑1 expression in oral squamous cell carcinoma (OSCC), and its association with prognosis were investigated in 128 patients with OSCC, treated at the Qilu Hospital of Shandong University and followed up for an additional 10 years. Immunohistochemical analysis was performed to detect ID‑1 expression, and the association between ID‑1 expression and recurrence, and estimated disease‑specific survival (DSS) time were subsequently analyzed using the Mann‑Whitney U test and the Kaplan‑Meier method, respectively. In addition, the log‑rank test was implemented to compare the survival curves and multivariate Cox proportional hazards analysis was performed to assess the prognostic value of ID‑1. The results demonstrated that ID‑1 was highly expressed in the majority of OSCC tissues investigated, and ID‑1 expression was significantly higher in cases with recurrence of local tumors and lymph node metastasis. Furthermore, higher ID‑1 expression levels were associated with a shorter DSS time. Taken together, the results of the present study suggest that ID‑1 may serve as an independent prognostic factor to predict DSS time in patients with OSCC.
View Figures
View References

Related Articles

Journal Cover

June-2020
Volume 19 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Zhang F, Wang D, Yang Z, Liu S and Dong Z: Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma. Oncol Lett 19: 3917-3922, 2020
APA
Chen, J., Zhang, F., Wang, D., Yang, Z., Liu, S., & Dong, Z. (2020). Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma. Oncology Letters, 19, 3917-3922. https://doi.org/10.3892/ol.2020.11506
MLA
Chen, J., Zhang, F., Wang, D., Yang, Z., Liu, S., Dong, Z."Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma". Oncology Letters 19.6 (2020): 3917-3922.
Chicago
Chen, J., Zhang, F., Wang, D., Yang, Z., Liu, S., Dong, Z."Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma". Oncology Letters 19, no. 6 (2020): 3917-3922. https://doi.org/10.3892/ol.2020.11506